SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008378
Filing Date
2017-11-07
Accepted
2017-11-07 16:06:07
Documents
53
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20170930x10q.htm 10-Q 1615620
2 EX-10.1 rigl-20170930ex101b67bde.htm EX-10.1 183371
3 EX-31.1 rigl-20170930ex311e52346.htm EX-31.1 17809
4 EX-31.2 rigl-20170930ex31265d8c3.htm EX-31.2 17831
5 EX-32.1 rigl-20170930ex32182c47d.htm EX-32.1 9499
  Complete submission text file 0001558370-17-008378.txt   4977250

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20170930.xml EX-101.INS 928642
7 EX-101.SCH rigl-20170930.xsd EX-101.SCH 33298
8 EX-101.CAL rigl-20170930_cal.xml EX-101.CAL 36826
9 EX-101.DEF rigl-20170930_def.xml EX-101.DEF 105945
10 EX-101.LAB rigl-20170930_lab.xml EX-101.LAB 289551
11 EX-101.PRE rigl-20170930_pre.xml EX-101.PRE 206279
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 171183401
SIC: 2834 Pharmaceutical Preparations